Sevamob

03/11/2026

Sevamob receives Distinguished CSR Partner award from Landmark for impact delivered by its intervention for factory workers.

​

01/02/2026

Sevamob starts primary healthcare service in partnership with NTPC Kawas

12/30/2025

Sevamob is the implementation partner of this intervention that has won the Best Rural Healthcare Initiative of the Year award at the Indian Social Impact Awards 2025.

https://www.linkedin.com/posts/sterlite-technologies-ltd-_stl-progresswithpurpose-csr-activity-7411337783979630592-OELT?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAvJ95UBiesskYwRh_TcJY8OAPuOBVs2D8o

12/03/2025

https://ijsrp.org/research-paper-1125.php?rp=P16714043

Introduction: Health assessments are systematic evaluations used to determine a person’s overall health status.

11/14/2025

https://www.ijsrp.org/research-paper-1025.php?rp=P16613995

Symptom-based triage and risk assessment is often the first step in patient triage but can be highly subjective, time-consuming, and prone to error, especially in resource-limited settings.

11/06/2025

Sevamob starts comprehensive primary healthcare for low income communities in 3 states of India in partnership with Landmark Cares

09/30/2025

Bee Formless podcast host Belinda Murray's discussion with Sevamob CEO Shelley Saxena.

A grounded, high-energy conversation with Shelley Saxena (Founder & CEO, Sevamob) on life, leadership and business from the inside out - startup reality (and...

09/27/2025

Sevamob LabReportAI: Automated Clinical Lab Report Analysis

Sevamob has developed LabReportAI, an artificial intelligence tool designed to analyze patient laboratory reports in diverse formats including images, PDFs, and structured form inputs. The system generates both “Results” and “Recommendations” to support clinical decision-making.

In a clinical study involving 140 patient cases, Sevamob LabReportAI outputs were compared against an independent panel of physicians who reviewed the same laboratory reports. Out of 140 cases, the AI system successfully provided results in 134 cases (95.7%). Six cases yielded no AI output due to report quality or data parsing limitations or not sufficient details available to produce results and recommendations. Of the evaluable cases, concordance with the physician panel was observed in 133 out of 135 cases (98.5%). Only one discordant (incorrect) result was noted.

These findings suggest that Sevamob LabReportAI demonstrates high accuracy and reliability, with potential for augmenting physician workflows in routine lab data interpretation while reducing turnaround time. Further large-scale validation studies are warranted to assess scalability across diverse patient populations and lab reporting formats.

09/26/2025

Sevamob starts primary healthcare service in Faridabad in partnership with Veedol.

07/26/2025

SEVAMOB'S AI BASED TUBERCULOSIS SCREENING - NOW ENHANCED WITH XRAY AI

Sevamob has developed XrayAI, which screens for Tuberculosis in chest xray images. In a Phase 2 clinical study, this AI had a Sensitivity of ~100%, Negative predictive value of ~100% and an overall accuracy of 73% when its results were compared to those of a panel of radiologists. This makes it ideal for Tuberculosis screening.

With this addition, Sevamob now has one of the most comprehensive screening solutions for Tuberculosis in the industry. This includes:
* SymptomsAI to perform triage
* SputumAI to screen for TB in sputum samples. This can operate offline in low resource settings
* XrayAI to screen for TB in chest xray images

07/17/2025

In an era where technology is reshaping every aspect of our lives, healthcare stands to benefit tremendously from innovative solutions—particularly in regions where resources are limited and access to quality care remains a challenge. Since 2015, The Pfizer Foundation's Global Health Innovation Gr...

05/03/2025

We are excited to announce the successful closure of our 𝗦𝗲𝗿𝗶𝗲𝘀 𝗕 𝗕𝗿𝗶𝗱𝗴𝗲 𝗥𝗼𝘂𝗻𝗱 which was led by 𝗚𝗹𝗼𝗯𝗮𝗹 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹𝘀' founder Dr Ravindranath. This round is a strong validation of Sevamob’s AI-powered primary care model and marks a significant milestone in our ten year journey.

Sevamob's platform integrates 𝗔𝗜-𝗲𝗻𝗮𝗯𝗹𝗲𝗱 𝗽𝗼𝗶𝗻𝘁-𝗼𝗳-𝗰𝗮𝗿𝗲 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴, 𝘁𝗲𝗹𝗲𝗵𝗲𝗮𝗹𝘁𝗵, and mobile clinics to deliver affordable, high-quality primary care reducing costs by nearly 50%. With Global Hospitals’ leadership in healthcare infrastructure, this round paves the way for Sevamob to scale deeper into underserved markets and forge new partnerships with 𝗡𝗚𝗢𝘀, 𝗶𝗻𝘀𝘂𝗿𝗲𝗿𝘀, 𝗮𝗻𝗱 𝗴𝗼𝘃𝗲𝗿𝗻𝗺𝗲𝗻𝘁 𝗵𝗲𝗮𝗹𝘁𝗵 𝗯𝗼𝗱𝗶𝗲𝘀.